Sign in to view content

Canadian Treat-and-Extend Analysis Trial with Ranibizumab in Patients With Neovascular AMD: CANTREAT Study 1-Year Results

Peter J. Kertes, MD, FRCS(C)

Video
Published 2018

Related

Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial
Nancy M. Holekamp, MD, FASRS
Updates from the Field
2016
Primary Results for Protocol AB
Andrew N. Antoszyk, MD FASRS
Updates from the Field
2020
Novel Vascular Endothelial Growth-Factor A (VEGF-A) and Angiopoietin-2 (Ang-2) Bispecific Protein, RO-634, in Comparison to Aflibercept
Mark R. Barakat, MD
Annual Meeting Talks
2022

Category: AMD-Neovascular

See more